Akums Drugs & Pharma's IPO, which ran from July 30 to August 1, saw its shares list at Rs 725 on both BSE and NSE, reflecting a 6.77% premium over the issue price of Rs 679.
The company offered shares in a fixed price band of Rs 646-679, raising Rs 1,856.74 crore. The IPO was highly subscribed, with 63.56 times overall demand, including 90.09 times for institutional investors. Akums, a CDMO since 2004, manufactures and sells branded drugs and APIs. Brokerage firms recommended long-term investment in the stock.